Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- 23 January 2014
- journal article
- practice guideline
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 95 (4), 376-382
- https://doi.org/10.1038/clpt.2013.254
Abstract
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 activity. Polymorphisms are a major cause of CYP2D6 variability. We summarize evidence from the literature supporting this association and provide therapeutic recommendations for codeine based on CYP2D6 genotype. This document is an update to the 2012 Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2D6 genotype and codeine therapy.Keywords
This publication has 40 references indexed in Scilit:
- A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast MilkPLOS ONE, 2013
- More Codeine Fatalities After Tonsillectomy in North American ChildrenPediatrics, 2012
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) GenotypeClinical Pharmacology & Therapeutics, 2011
- Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre studyEuropean Journal of Clinical Pharmacology, 2011
- Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyBritish Journal of Pharmacology, 2010
- The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBritish Journal of Pharmacology, 2010
- Impact of the CYP2D6 genotype on post‐operative intravenous oxycodone analgesiaActa Anaesthesiologica Scandinavica, 2010
- Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?Pain, 2009
- Developmental Changes in Human Liver CYP2D6 ExpressionDrug Metabolism and Disposition, 2008
- Apnea in a child after oral codeine: a genetic variant – an ultra‐rapid metabolizerPediatric Anesthesia, 2007